Dendritic cells in Plasmodium infection

Future Microbiology

Volumn 3, Issue 3, 2008, Pages 279-286

  Todryk, Stephen M ^a,b   Urban, Britta C ^b,c  

^a NORTHUMBRIA UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

Author keywords

Activation; Dendritic cell; Immune response; Malaria; Plasmodium; Suppression

Indexed keywords

ANTIMALARIAL AGENT; DNA VACCINE; HEMOZOIN; MALARIA VACCINE; VIRUS VECTOR;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; APOPTOSIS; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; CELL MIGRATION; DENDRITIC CELL; DRUG INTERMITTENT THERAPY; ERYTHROCYTE; GAMETOCYTE; HOST PARASITE INTERACTION; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOPATHOLOGY; INFLAMMATION; LIFE CYCLE; LIVER CELL; LOW DRUG DOSE; LYMPHOCYTE ACTIVATION; MALARIA; MEROZOITE; MORBIDITY; MORTALITY; NONHUMAN; PARASITE SURVIVAL; PATHOGENESIS; PLASMODIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SCHIZONT; SPOROZOITE; VACCINATION; VACCINE PRODUCTION; ANIMAL; IMMUNOLOGY; PHYSIOLOGY;

HARNESS; PLASMODIUM PARASITES; PROTOZOA;

ANIMALS; DENDRITIC CELLS; HUMANS; MALARIA; PLASMODIUM;

EID: 46049109379     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460913.3.3.279     Document Type: Review

References (54)

1. Artavanis-Tsakonas K, Tongren JE, Riley EM: The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology. Clin. Exp. Immunol. 133, 145-152 (2003).
2. Todryk SM, Hill AV: Malaria vaccines: the stage we are at. Nat. Rev. Microbiol. 5, 487-489 (2007).
3. Lamb TJ, Brown DE, Potocnik AJ, Langhorne J: Insights into the immunopathogenesis of malaria using mouse models. Expert Rev. Mol. Med. 8(6), 1-22 (2006).
4. Shortman K, Liu YJ: Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2, 151-161 (2002).
5. Kaisho T, Akira S: Regulation of dendritic cell function through Toll-like receptors. Curr. Mol. Med. 3, 759-771 (2003).
6. Park CS, Choi YS: How do follicular dendritic cells interact intimately with B cells in the germinal centre? Immunology 114, 2-10 (2005).
7. Medica DL, Sinnis P: Quantitative dynamics of Plasmodium yoelii sporozoite transmission by infected anopheline mosquitoes. Infect. Immun. 73(7), 4363-4369 (2005).
8. Amino R, Thiberge S, Martin B et a.: Quantitative imaging of Plasmodium transmission from mosquito to mammal. Nat Med. 12(2), 220-224 (2006).
9. Sturm A, Amino R, van de Sand C et al.: Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science 313(5791), 1287-1290 (2006).
10. Patel SN, Lu Z, Ayi K et al.: Disruption of CD36 impairs cytokine response to Plasmodium falciparum glycosylphosphatidylinositol and confers susceptibility to severe and fatal malaria in vivo. J. Immunol. 178(6), 3954-3961 (2007)
11. Yazdani SS, Mukherjee P, Chauhan VS, Chitnis CE: Immune responses to asexual blood-stages of malaria parasites. Curr Mol. Med. 6(2), 187-203 (2006).
12. Langhorne J, Albano FR, Hensmann M et al.: Dendritic cells, pro-inflammatory responses, and antigen presentation in a rodent malaria infection. Immunol. Rev. 201, 35-47 (2004).
13. Alonso PL: Malaria: deploying a candidate vaccine (RTS,S/AS02A) for an old scourge of humankind. Int. Microbiol. 9(2), 83-93 (2006).
14. high T cells with susceptibility in Kenyans. PloS ONE3(4), e2027 (2008).
15. Luty AJ, Lell B, Schmidt-Ott R et al.: Interferon-γ responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. J Infect. Dis. 179(4), 980-988 (1999).
16. Webster DP, Dunachie S, Vuola JM et al.: Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara. Proc. Natl Acad. Sci. USA 102(13), 4836-4841 (2005).
17. Pombo DJ, Lawrence G, Hirunpetcharat C et al.: Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet 360(9333), 610-617 (2002).
18. Guevara Patiño JA, Holder AA, McBride JS, Blackman MJ: Antibodies that inhibit malaria merozoite-surface-protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. J. Exp. Med. 186(10), 1689-1699 (1997).
19. Roussilhon C, Oeuvray C, Müller-Graf C et al.: Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. PLoS Med. 4(11), e320 (2007).
20. Neble I, Diarra A, Ouedraogo A et al.: Humoral responses to P. falciparum blood stage antigens and association with incidence of clinical malaria in children living in a seasonal malaria transmission area of Burkina Faso, West Africa. Infect. Immun. 76(2). 759-766 (2007).
21. Greenwood BM, Bradley-Moore AM, Bryceson AD, Palit A: Immunosuppression in children with malaria. Lancet (7743), 169-172 (1972).
22. Warren HS, Weidanz WP: Malarial immunodepression in vitro: adherent spleen cells are functionally defective as accessory cells in the response to horse erythrocytes. Eur. J. Immunol. 6 (11), 816-819 (1976).
23. Urban BC, Ferguson DJ, Pain A et al.: Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 400(6739), 73-77 (1999).
24. Urban BC, Willcox N, Roberts DJ: A role for CD36 in the regulation of dendritic cell function. Proc. Natl Acad. Sci. USA 98(15), 8750-8755 (2001).
25. Elliott SR, Spurck TP, Dodin JM et al.: Inhibition of dendritic cell maturation by malaria is dose dependent and does not require Plasmodium falciparum erythrocyte membrane protein 1. Infect. Immun. 75(7), 3621-3632 (2007).
26. Skorokhod OA, Alessio M, Mordmüller B, Arese P, Schwarzer E: Hemozoin (malarial pigment) inhibits differentiation and maturation of human monocyte-derived dendritic cells: a peroxisome proliferator-activated receptor-gamma-mediated effect. J. Immunol. 173(6), 4066-4074 (2004).
27. Pichyangkul S, Yongvanitchit K, Kum-arb U et al.: Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway. J. Immunol. 172(8), 4926-4933 (2004).
28. Urban BC, Mwangi T, Ross A et al.: Peripheral blood dendritic cells in children with acute Plasmodium falciparum malaria. Blood 98(9), 2859-2861 (2001).
29. Urban BC, Cordery D, Shafl MJ et al.: The frequency of BDCA3-positive dendritic cells is increased in the peripheral circulation of Kenyan children with severe malaria. Infect. Immun. 74(12), 6700-6706 (2006).
30. Ing R, Segura M, Thawani N, Tam M, Stevenson MM: Interaction of mouse dendritic cells and malaria-infected erythrocytes: uptake, maturation, and antigen presentation. J. Immunol. 176(1), 441-450 (2006).
31. Leisewitz AL, Rockett KA, Gumede B et al.: Response of the splenic dendritic cell population to malaria infection. Infect. Immun. 72(7), 4233-4239 (2004).
32. Millington OR, Gibson VB, Rush CM et al.: Malaria impairs T-cell clustering and immune priming despite normal signal 1 from dendritic cells. PLoS Pathog. 3(10), 1380-1387 (2007).
33. Millington OR, Di Lorenzo C, Phillips RS, Garside P, Brewer JM: Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function. J. Biol. 5(2), 5 (2006).
34. Coban C, Ishii KJ, Kawai T et al.: Toll-like-receptor-9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 201(1), 19-25 (2005).
35. Parroche P, Lauw FN, Goutagny N et al.: Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor-9. Proc. Natl Acad. Sci. USA 104(6), 1919-1924 (2007).
36. deWalick S, Amante FH, McSweeney KA et al.: Cutting edge: conventional dendritic cells are the critical APC required for the induction of experimental cerebral malaria. J. Immunol. 178(10), 6033-6037 (2007).
37. + T lymphocytes mediates symptoms, but is not required for the immunological control of parasites during rodent malaria. Microbes Infect, 9(7), 881-890 (2007).
38. Carapau D, Kruhofer M, Chatalbash A et al.: Transcriptome profile of dendritic cells during malaria: cAMP regulation of IL-6. Cell. Microbiol. 9(7), 1738-1752 (2007).
39. + T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes. Nat. Med. 13(9), 1035-1041 (2007).
40. Sponaas AM, Cadman ET, Voisine C et al.: Malaria infection changes the ability of splenic dendritic cell populations to stimulate antigen-specific T cells. J. Exp. Med. 203(6), 1427-1433 (2006).
41. Wilson NS, Behrens GM, Lundie RJ et al.: Systemic activation of dendritic cells by Toll-like-receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat. Immunol. 7(2), 165-172 (2006).
42. + T cell cycle arrest during priming as a consequence of dendritic cell interaction with Plasmodium-infected red cells. J. Immunol. 175(6), 3525-3533 (2005).
43. Pouniotis DS, Proudfoot O, Bogdanoska V et al.: Dendritic cells induce immunity and long-lasting protection against blood-stage malaria despite an in vitro parasite-induced maturation defect. Infect. Immun. 72(9), 5331-5339 (2004).
44. Bruna-Romero O, Schmieg J, Del Val M, Buschle M, Tsuji M: The dendritic cell-specific chemokine, dendritic cell-derived CC chemokine 1, enhances protective cell-mediated immunity to murine, malaria. J. Immunol. 170(6), 3195-3203 (2003).
45. Wykes MN, Liu XQ, Beattie L et al.: Plasmodium strain determines dendritic cell function essential for survival from malaria. PLoS Pathog. 3(7), e96 (2007).
46. Perry JA, Olver CS, Burnett RC, Avery AC: Cutting edge: the acquisition of TLR tolerance during malaria infection impacts T cell activation. J. Immunol. 174(10), 5921-5925 (2005).
47. Wykes MN, Liu XQ, Jiang S, Hirunpetcharat C, Good MF: Systemic tumor necrosis factor generated during lethal Plasmodium infections impairs dendritic cell function. J. Immunol. 179(6), 3982-3987 (2007).
48. Wong KA, Rodriguez A: Plasmodium infection and endotoxic shock induce the expansion of regulatory dendritic cells. J. Immunol. 180(2), 716-726 (2008).
49. Ocaña-Morgner C, Wong KA, Lega F et al.: Role of TGF-β and PGE2 in T cell responses during Plasmodium yoelii infection. Eur. J. Immunol. 37(6), 1562-1574 (2007).
50. Bejon P, Mwacharo J, Kai O et al.: The induction and persistence of T-cell IFN-γ responses after vaccination or natural exposure is suppressed by Plasmodium falciparum. J. Immunol. 179(6), 4193-4201 (2007).
51. + regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity 23 (3), 287-296 (2005).
52. Newman KC, Riley EM Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat. Rev. Immunol. 7(4), 279-291 (2007).
53. Cui Z: DNA vaccine. Adv. Genet. 54, 257-289 (2005).
54. Munday S: Review of intermittent preventive treatment for malaria in infants and children. J. Pediatr. Child Health 43(6), 424-428 (2007).